54
Participants
Start Date
May 23, 2011
Primary Completion Date
October 2, 2018
Study Completion Date
October 2, 2018
Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001
Given IV
Laboratory Biomarker Analysis
Correlative studies
Montefiore Medical Center-Einstein Campus, The Bronx
Sinai Hospital of Baltimore, Baltimore
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Virginia Commonwealth University/Massey Cancer Center, Richmond
Carolinas Medical Center/Levine Cancer Institute, Charlotte
Memorial Health University Medical Center, Savannah
University of Alabama at Birmingham Cancer Center, Birmingham
Ohio State University Comprehensive Cancer Center, Columbus
UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor
Case Western Reserve University, Cleveland
University of Michigan Comprehensive Cancer Center, Ann Arbor
Froedtert and the Medical College of Wisconsin, Milwaukee
Washington University School of Medicine, St Louis
University of Kansas Cancer Center, Kansas City
University of Oklahoma Health Sciences Center, Oklahoma City
Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Saint Joseph's Hospital and Medical Center, Phoenix
Los Angeles County-USC Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles
UC San Diego Moores Cancer Center, La Jolla
UCSF Medical Center-Mount Zion, San Francisco
UCSF Medical Center-Mission Bay, San Francisco
University of Texas Medical Branch, Galveston
Collaborators (1)
Advaxis, Inc.
INDUSTRY
National Cancer Institute (NCI)
NIH
Gynecologic Oncology Group
NETWORK